Categories : Oncology
Product Packaging : 30 in HDPE
Product Composition : 250mg
Lapatinib tablets are targeted oncology medicines used primarily in the treatment of HER2-positive breast cancer. As a dual tyrosine kinase inhibitor, the formulation blocks both HER2 and EGFR pathways, helping to slow tumor growth and progression in patients requiring advanced targeted therapy.
In international pharmaceutical markets, Lapatinib tablets exporter India and breast cancer medicine supplier India are commonly searched by oncology distributors and importers. Genliva Wellness LLP, Himatnagar, operates as a pharma exporter India oncology medicines partner, supplying targeted therapy formulations to global pharmaceutical companies, healthcare institutions, and cancer treatment providers.
Send MessageLapatinib tablets are targeted oncology medicines used primarily in the treatment of HER2-positive breast cancer. As a dual tyrosine kinase inhibitor, the formulation blocks both HER2 and EGFR pathways, helping to slow tumor growth and progression in patients requiring advanced targeted therapy.
In international pharmaceutical markets, Lapatinib tablets exporter India and breast cancer medicine supplier India are commonly searched by oncology distributors and importers. Genliva Wellness LLP, Himatnagar, operates as a pharma exporter India oncology medicines partner, supplying targeted therapy formulations to global pharmaceutical companies, healthcare institutions, and cancer treatment providers.
